Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 80Neoplasms 61Colorectal Neoplasms 42Prostatic Neoplasms 41Carcinoma, Non-Small-Cell Lung 35Lung Neoplasms 31Multiple Myeloma 23Leukemia, Myeloid, Acute 23Head and Neck Neoplasms 22Pancreatic Neoplasms 15Melanoma 15Squamous Cell Carcinoma of Head and Neck 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Ovarian Neoplasms 14Neoplasm Metastasis 14Carcinoma, Hepatocellular 14Recurrence 13Lymphoma, Non-Hodgkin 13Stomach Neoplasms 12Colonic Neoplasms 11Uterine Cervical Neoplasms 10Rectal Neoplasms 10Lymphoma 10Esophageal Neoplasms 10Carcinoma, Renal Cell 10Brain Neoplasms 10Motor Activity 9Kidney Neoplasms 9Myelodysplastic Syndromes 8Lymphoma, Large B-Cell, Diffuse 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Adenocarcinoma of the Prostate × 30 days × Clear all
NCT02761889 2026-05-12

Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer

Fundacao Champalimaud

Phase NA Completed
444 enrolled
Genitourinary

Adenocarcinoma of the Prostate

Data powered by HemOnc (CC BY 4.0) Colophon âš¡